1. Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR) 
Richard B. Warren, Catherine H. Smith, Zenas Z.N. Yiu, Darren M. Ashcroft, Jonathan N.W.N. Barker, A. David Burden, Mark Lunt, Kathleen McElhone, Anthony D. Ormerod, Caroline M. Owen, Nick J. Reynolds, Christopher E.M. Griffiths 
Journal of Investigative Dermatology 
Volume 135, Issue 11, Pages (November 2015)
DOI: /jid
Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

2. Figure 1
Crude drug survival of the first biologic course showing disaggregated biologic data (Kaplan–Meier survival curve).
Journal of Investigative Dermatology  , DOI: ( /jid )
Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

3. Figure 2
Adjusted drug survival curves using disaggregated data based on the overall multivariate Cox proportional hazard model in Table 4.
Journal of Investigative Dermatology  , DOI: ( /jid )
Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions